Correction: Assessment of Interleukin-10 Levels in Iraqi Diabetic Type 2 Patients Infected with Toxoplasmosis

Abstract

This corrects "Assessment of Interleukin-10 Levels in Iraqi Diabetic Type 2 Patients Infected with Toxoplasmosis." Adv. Life Sci. 2023 Oct;10S(1):62–66. doi: 10.62940/als.v10i0.2025.

Following the publication of this article, an internal audit — conducted in response to quality concerns raised by Web of Science — identified suspected plagiarism in the originally published version. Upon investigation, it was determined that the similarity detected (27%) was attributable to the use of reference values and recurring sequences of commonly employed phrases rather than actual plagiarism. The records have since been reconciled, and the article has additionally undergone minor language corrections. The Editorial Expression of Concern issued on 20 June 2025 has accordingly been withdrawn. The earlier published copy of this article is available on request at als.editor@als-journal.com.

The Advancements in Life Sciences Editorial Office regrets that these issues were not identified prior to publication.

History of the correction process

Editorial Expression of Concern

20 June 2025: Following publication of this paper, the internal audit (consequent to concerns on quality raised by Web of Science) notified Advancements in Life Sciences about suspected plagiarism. By this Editorial Expression of Concern, we alert the scientific community of the errors as we reconcile the records.

Editorial Note

25 June 2025: Mention of reference values and similar usage sequence of commonly used parts of phrases have been found as major sources of total verbatim similarity (27%). Therefore, it may not be considered as plagiarism. Hence, the Editorial Expression of Concern is revoked.

25 June 2025: This article has been updated with language corrections.